Menopause (New York, N.Y.)HumansFemaleAspirinMiddle AgedHydroxymethylglutaryl-CoA Reductase Inhibitors
Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women's Health Initiative trial.
John W Davis, Aaron K Aragaki, Laura B Harrington, Jacques E Rossouw, Gretchen Wells, Aladdin Shadyab, Peter F Schnatz, Chrisandra L Shufelt, Lisa Warsinger-Martin, Robert A Wild, JoAnn E Manson
Published: 202610.1097/GME.0000000000002647
Abstract
OBJECTIVE: To evaluate whether effects of oral hormone therapy (HT) on risks of venous and arterial vascular events differ by baseline statin or aspirin use. METHODS: We performed time-to-event analysis using data from the Women's Health Initiative m…
Preview only. Read the full abstract at the source